公式財務諸表に基づく売上高、利益、キャッシュフローの推移。
Oscar Health, Inc. operates as a healthcare technology company in the United States. The company offers health plans to individuals, families, employees, and small group markets. It also provides +Oscar platform that power others throughout the healthcare system; Campaign Builder platform, an engagement and recommendation platform for providers and payors; and reinsurance products. In addition, the company offers brokerage services and enrollment platform for brokers and consumers to shop, buy, and enroll in medical and supplemental health products.
インタラクティブチャートと全財務諸表を見る → バリュエーションモデル（DCF）→
| 損益計算書 | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|---|---|---|
| 売上高合計 | $15.3B | $11.7B | $9.2B | $5.9B | $4.1B | $1.9B | $590M | $554M |
| 売上総利益 | — | $1.7B | $1.8B | $5.9B | $4.1B | $1.9B | $590M | $554M |
| 売上総利益率 % | — | 14.4% | 20.1% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| 営業利益（EBIT） | — | ($396M) | $57M | ($236M) | ($610M) | ($571M) | ($406M) | ($259M) |
| 営業利益率 % | — | -3.4% | 0.6% | -4.0% | -14.8% | -29.7% | -68.8% | -46.8% |
| 当期純利益 | $551M | ($443M) | $25M | ($271M) | ($606M) | ($573M) | ($407M) | ($261M) |
| 純利益率 % | 3.6% | -3.8% | 0.3% | -4.6% | -14.7% | -29.8% | -69.0% | -47.2% |
| EBITDA | — | ($391M) | $89M | ($236M) | ($572M) | ($551M) | ($391M) | ($252M) |
| 1株当たり利益（EPS） | $1.39 | $-1.69 | $0.10 | $-1.22 | $-2.85 | $-3.20 | $-13.90 | $-9.06 |
| 発行済株式数（百万株） | — | 262M | 266M | 222M | 212M | 179M | 29M | 29M |
出典: 企業の公開資料（SEC）。数値をご利用の前に SEC EDGAR でご確認ください。
貸借対照表、キャッシュフロー計算書、四半期データおよび全財務比率は OSCR のインタラクティブ・ビューアーでご覧いただけます。 /companies/us/OSCR
本サイトの情報は教育および情報提供のみを目的としており、投資助言ではありません。目標株価や投資判断は掲載していません。
About TickerBase · Data methodology & sources · Privacy · Terms